Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-10-05
1997-06-10
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514 28, 514 29, 514 30, 514251, 514291, 514457, 514513, 514538, 514549, 514552, 514554, 514555, 554 85, 554101, 554102, 558230, 558256, 558257, 560 16, 560147, 560153, 562426, 562557, C07C32359, A61K 31195, A61K 3120
Patent
active
056376162
ABSTRACT:
A method for the topical or systemic treatment of disorders mediated by proteases which result in skin or mucosal lesions, and in particular, pemphigus, cicatricial pemphigoid, bullous pemphigoid, lichen planus, and canker sores, is disclosed wherein the host is treated with an effective amount of N-acetyl ysteine or a derivative thereof, or its pharmaceutically acceptable salt, optionally in a pharmaceutically acceptable diluent or carrier for systemic or topical delivery.
REFERENCES:
patent: 4354023 (1982-10-01), Falciani et al.
patent: 4414387 (1983-11-01), Broggi et al.
patent: 4440788 (1984-04-01), Terayama et al.
patent: 4476120 (1984-10-01), Gonella
patent: 4567163 (1986-01-01), Ponchiroli
patent: 4847282 (1989-07-01), Deboeck
patent: 4861764 (1989-08-01), Samour et al.
patent: 4970236 (1990-11-01), Ziggiotti et al.
patent: 5073641 (1991-12-01), Bundgaard et al.
patent: 5080906 (1992-01-01), Carenzi et al.
patent: 5124062 (1992-06-01), Stevens
patent: 5173510 (1992-12-01), Bloom et al.
patent: 5182271 (1993-01-01), Houlihan
patent: 5212316 (1993-05-01), Spinelli et al.
patent: 5256408 (1993-10-01), Babcock et al.
patent: 5296500 (1994-03-01), Hillebrand
Abdel-Rahman R.M. et al., "Synthesis of Some New Thioesters of 1,2,4-Triazine-3-Hydrazones and Assays for their Anticancer and Anti Human Immune Virus Activities," II Farmaco, 1993, vol. 48 (3), pp. 397-406.
Ahmed, A.R., et al., mod., UCLA Conference, "Pemphigus: Current Concepts," Annals of Internal Medicine, 1980, vol. 92, pp. 396-405.
Anhalt, Labib, Voorhees, Beals and Diaz, "Induction of Pemphigus in Neonatal Mice by Passive Transfer of I.sub.G G From Patients with the Disease," N. Engl. J. Med. 1982, vol. 306, pp. 1189-1196.
Anhalt, Till, Diaz, Labib, Patel and Eaglstein, "Defining the Role of Complement in Experimental Pemphigus vulgaris in Mice," J. Immunol. 1986, vol. 137, pp. 2835-2840.
Arndt, K. "Lichen planus," Fitzpatrick, Eisen, Wolff, Freedberg and Austen, Dermatology in General Medicine, 1987, vol. 1, McGraw-Hill, Inc., New York, pp. 967-973.
Arndt, K.A., Mendenhall, P.V., "The Pharmacology of Topical Therapy", Dermatology in General Medicine, 1987; Fitzpatrick, Eisen, Wolff, Freeberg, Austen, eds., 3d ed., McGraw Hill, Inc., New York, pp. 582-584, 2532-2540.
Aruoma, O.I., et al., "The Antioxidant Action of N-Acetylcysteine: Its Reaction with Hydrogen Peroxide, Hydroxyl Radical, Superoxide, and Hypochlorous Acid," Free Radical Biology & Medicine, vol. 6, 1989, pp. 593-597.
Baden, L.A., "Bullous pemphigoid," Manual of Clinical Problems in Dermatology, Little, Brown & Co., Boston, 1992, p. 54.
Banks, B.J., et al., "Phenylthionitromethane; a Versatile Reagent for the Conversion of Aldehydes into .alpha.-Substituted S-Phenyl Thioesters," J. Chem. Soc., Chem. Commun., 1984, p. 670.
Barnhart, et al., "Proteases in Inflammation," Annals of N.Y. Acad. Sci., 1968, pp. 526-539.
Berggren, M., et al., "Glutathione biosynthesis in the isolated perfused rat lung: utilization of extracellular glutathione," FEBS Lett., 1984, vol. 176, pp. 189-192.
Betageri, G.V., et al., "Drug Delivery Using Antibody-Liposome Conjugates," Drug Development and Industrial Pharmacy 1993, vol. 19, No. 16, 2109-2116.
Bigby, S.M., and Arndt, K.A, "Chronic Oral Ulcerations," Manual of Clinical Dermatology, Little, Brown & Co., Boston, 1992, pp. 314-315.
Bleicher, P.A., "Lichen planus and Related Disorders," Manual of Clinical Problems in Dermatology, Olbricht, Bigby and Arndt, eds. 1992, Little, Brown & Co., Boston, pp. 85-89.
Christophers, E., et al., "Psoriasis," Dermatology in General Medicine, 1987; Fitzpatrick, Eisen, Wolff, Freeberg, Austen, eds., 3d ed., McGraw Hill, Inc., New York, pp. 461-491.
Dubertret, L., et al., "Localization of Proteolytic Activity in Psoriatic Skin," British Journal of Dermatology 1992, vol. 107, pp. 499-504.
Eisen, Ellis, Duell, Griffiths and Voorhees, "Effect of Topical Cyclosporine Rinse on Oral Lichen planus," N. Engl. J. Med., 1990, vol. 323, pp. 290-294.
Ellis, Dodson, Police, "Restoration of Cerebrovascular Responsiveness to Hyperventilation by the Oxygen Radical Scavenger N-Acetycysteine Following Experimental Traumatic Brain Injury," J. Neurosurg., 1991, vol. 75, pp. 774-779.
Fraki, J., et al., "Human Skin Proteases," Arch. Derm. Res., 1976, vol. 256, pp. 113-126.
Forster, "Nature and Origin of Proteases in the Immunologically Induced Inflammatory Reaction," J. Dent. Res., 1972, vol. 51, pp. 257-263.
Gerschman, R., et al., "Effect of Various Substances on Survival times of Mice Exposed to Different High Oxygen Tensions," Amer. J. Physiol., 1958, vol. 192, pp. 563-571.
Glinski, W., et al., "The Activity of Polymorphonuclear Leukocyte Neutral Proteinases and Their Inhibitors in Patients with Psoriasis Treated with a Continuous Peritoneal Dialysis," J. Investigative Dermatology, 1980, vol. 75, No. 6, pp. 481-487.
Grando, et al., "Cytotoxic proteases in blister fluid of pemphigus and pemphigoid patients," Int. J. Tissue React. 1989, vol. 11, pp. 195-201.
Grando, et al., "Mediators of Inflammation in Blister Fluids From Patients With Pemphigus vulgaris and Bullous pemphigoid," Arch. Dermatol., 1989, vol. 125, pp. 925-930.
Hong, C., et al., "Synthesis and Antitumor Activity of 1-.beta.-D-Arabinofuranosylcytosine Conjugates of Optical Isomers of Ether and Thioether Lipids," Lipids, 1993, vol. 28, No. 11, pp. 1021-1026.
Iriuchijima, S., et al., "Organic Synthesis by the Pummerer Reaction. II. Synthesis of .alpha.-Hydroxy Acid Derivatives from .beta.-Keto Sulfoxides," J. Am. Chem. Soc., 1975, p. 97:596.
Janoff, A., et al., "Proteases, Antiproteases, and Oxidants: Pathways of Tissue Injury During Inflammation," Monogr. Pathol., 1982, vol. 23, pp. 62-82.
Jordon, R.E., "Pemphigus," Dermatology in General Medicine, McGraw Hill Book Co., 3rd ed., 1987, vol. 1, pp. 575-586.
Kikuchi, K., et al., "Metabolism and Penetration Through Blood-Brain Barrier of Parkinsonism-Related Compounds", Drug Met. and Dispos., 1991, 19(1), p. 257.
Knight, MacPhadyen, Lepore, Kuwata, Eadie, O'Brien, "Enhancement of Ischaemic Rabbit Skin Flap Survival with the Antioxidant and Free-Radical Scavenger N-Acetylcysteine," Clinical Sci., 1991, vol. 81, pp. 31-36.
Kohrt, A. et al., "Darstellung N-Geschutzer .alpha.-Aminodithiosaureester aus .alpha.-Aminonitrilen und .alpha.-Aminocarbonsauren," Liebigs Ann. Chem. 1992, pp. 595-605.
Lalitha, T., et al., "Effect of N-Acetyl-cysteine, D-Penicillamine and Buthionine Sulfoximine on Glutathione Levels and CNS Oxyten Toxicity in Rats," Pharmacology and Toxicology, 1990, vol. 66, pp. 56-61.
Lauharanta, Salonen and Vaheri, "Plasmin-like Proteinase Associated With High Molecular Weight Complexes in Blister Fluid of Bullous pemphigoid," Acta Derm. Venereol. 1989, vol. 69, pp. 527-529.
Lemp and Roddy, "The Effect of Acetylcysteine (Mucomyst) on Reepithelialization of the Cornea," Ann. Ophthalmol. 1974, vol. 6, pp. 893-895.
Lever, W.F., "Pemphigus and Pemphigoid," J. Am. Acad. Dermatol., 1979, vol. 1, pp. 2-31.
Lightowler and Lightowler, "Comparative Mucolytic Studies on Dithiothreitol, N-Acetylcysteine and L-Cysteine on Human Respiratory Mucus in vitro and their Effects on the Rate of flow of Mucus in the Exposed Trachea of the Rat on Topical Application," Arch. Int. Pharmacodyn. 1971, vol. 189, pp. 53-58.
Milligan, J.F., et al., "Current Concepts in Antisense Drug Design,"0 J. Med. Chem., 1993, vol. 36, pp. 1923-1937.
Morioka, Naito and Ogawa,"The Pathogenic Role of Pemphigus Antibodies and Proteinase in Epidermal Acantholysis, " J. Invest. Dermatol., 1981, vol. 76, pp. 337-341.
Morrison, Burnett and Stockley, "The Effect of Reducing Agents on Proteolytic Enzymes and Oxidation of .alpha..sub.1 -Proteinase Inhibitor,"0 Biol. Chem. Hoppe Seyler, 1986, vol. 367, pp. 117-182.
Naito, Morioka, Nakajima,Ogawa, "Proteinase Inhibitors Block Formation of Pemphigus Acantholysis in Experimental Models of Neonatal Mice and Skin Explants: Effects of Synthetic and Plasma Proteinase Inhibitors on Pemphigus Acantholysis," J. Invest. Dermatol., 1989, vol. 93, 173-177.
Ogino, K., et al., "Biochemical Reactions Involving Thioest
Arndt Kenneth A.
Galli Stephen J.
McAloon Maureen H.
Sharpe Richard J.
Arcturus Pharmaceutical Corporation
O'Sullivan Peter
LandOfFree
Method for treating diseases mediated by proteases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating diseases mediated by proteases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating diseases mediated by proteases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764926